Global Peptide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 131
Published Date: 04 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Peptide Vaccine market size was valued at USD 3789.6 million in 2023 and is forecast to a readjusted size of USD 5025.6 million by 2030 with a CAGR of 4.1% during review period.
Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Peptide Vaccine industry chain, the market status of Prostate Cancer (Solution Phase Synthesis (SPS), Solid Phase Peptide Synthesis (SPPS)), Breast Cancer (Solution Phase Synthesis (SPS), Solid Phase Peptide Synthesis (SPPS)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Peptide Vaccine.
Regionally, the report analyzes the Peptide Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Peptide Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Peptide Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Peptide Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Dose), revenue generated, and market share of different by Type (e.g., Solution Phase Synthesis (SPS), Solid Phase Peptide Synthesis (SPPS)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Peptide Vaccine market.
Regional Analysis: The report involves examining the Peptide Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Peptide Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Peptide Vaccine:
Company Analysis: Report covers individual Peptide Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Peptide Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Prostate Cancer, Breast Cancer).
Technology Analysis: Report covers specific technologies relevant to Peptide Vaccine. It assesses the current state, advancements, and potential future developments in Peptide Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Peptide Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Peptide Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Solution Phase Synthesis (SPS)
Solid Phase Peptide Synthesis (SPPS)
Market segment by Application
Prostate Cancer
Breast Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Others
Major players covered
Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptide Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Peptide Vaccine, with price, sales, revenue and global market share of Peptide Vaccine from 2019 to 2024.
Chapter 3, the Peptide Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptide Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Peptide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Peptide Vaccine.
Chapter 14 and 15, to describe Peptide Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Peptide Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Peptide Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Solution Phase Synthesis (SPS)
1.3.3 Solid Phase Peptide Synthesis (SPPS)
1.4 Market Analysis by Application
1.4.1 Overview: Global Peptide Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Prostate Cancer
1.4.3 Breast Cancer
1.4.4 Gastric Cancer
1.4.5 Lung Cancer
1.4.6 Pancreatic Cancer
1.4.7 Others
1.5 Global Peptide Vaccine Market Size & Forecast
1.5.1 Global Peptide Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Peptide Vaccine Sales Quantity (2019-2030)
1.5.3 Global Peptide Vaccine Average Price (2019-2030)
2.1 Anergis
2.1.1 Anergis Details
2.1.2 Anergis Major Business
2.1.3 Anergis Peptide Vaccine Product and Services
2.1.4 Anergis Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Anergis Recent Developments/Updates
2.2 Antigen Express
2.2.1 Antigen Express Details
2.2.2 Antigen Express Major Business
2.2.3 Antigen Express Peptide Vaccine Product and Services
2.2.4 Antigen Express Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Antigen Express Recent Developments/Updates
2.3 Apitope Technology
2.3.1 Apitope Technology Details
2.3.2 Apitope Technology Major Business
2.3.3 Apitope Technology Peptide Vaccine Product and Services
2.3.4 Apitope Technology Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Apitope Technology Recent Developments/Updates
2.4 Artificial Cell Technologies
2.4.1 Artificial Cell Technologies Details
2.4.2 Artificial Cell Technologies Major Business
2.4.3 Artificial Cell Technologies Peptide Vaccine Product and Services
2.4.4 Artificial Cell Technologies Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Artificial Cell Technologies Recent Developments/Updates
2.5 Benovus Bio
2.5.1 Benovus Bio Details
2.5.2 Benovus Bio Major Business
2.5.3 Benovus Bio Peptide Vaccine Product and Services
2.5.4 Benovus Bio Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Benovus Bio Recent Developments/Updates
2.6 Celgene Corporation
2.6.1 Celgene Corporation Details
2.6.2 Celgene Corporation Major Business
2.6.3 Celgene Corporation Peptide Vaccine Product and Services
2.6.4 Celgene Corporation Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Celgene Corporation Recent Developments/Updates
2.7 Immatics biotechnologies
2.7.1 Immatics biotechnologies Details
2.7.2 Immatics biotechnologies Major Business
2.7.3 Immatics biotechnologies Peptide Vaccine Product and Services
2.7.4 Immatics biotechnologies Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Immatics biotechnologies Recent Developments/Updates
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Peptide Vaccine Product and Services
2.8.4 Merck Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Merck Recent Developments/Updates
2.9 ImmunoCellular Therapeutics
2.9.1 ImmunoCellular Therapeutics Details
2.9.2 ImmunoCellular Therapeutics Major Business
2.9.3 ImmunoCellular Therapeutics Peptide Vaccine Product and Services
2.9.4 ImmunoCellular Therapeutics Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 ImmunoCellular Therapeutics Recent Developments/Updates
2.10 ISA Pharmaceuticals
2.10.1 ISA Pharmaceuticals Details
2.10.2 ISA Pharmaceuticals Major Business
2.10.3 ISA Pharmaceuticals Peptide Vaccine Product and Services
2.10.4 ISA Pharmaceuticals Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 ISA Pharmaceuticals Recent Developments/Updates
2.11 Lytix Biopharma
2.11.1 Lytix Biopharma Details
2.11.2 Lytix Biopharma Major Business
2.11.3 Lytix Biopharma Peptide Vaccine Product and Services
2.11.4 Lytix Biopharma Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Lytix Biopharma Recent Developments/Updates
2.12 Spotlight Innovation
2.12.1 Spotlight Innovation Details
2.12.2 Spotlight Innovation Major Business
2.12.3 Spotlight Innovation Peptide Vaccine Product and Services
2.12.4 Spotlight Innovation Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Spotlight Innovation Recent Developments/Updates
2.13 OncoTherapy Science
2.13.1 OncoTherapy Science Details
2.13.2 OncoTherapy Science Major Business
2.13.3 OncoTherapy Science Peptide Vaccine Product and Services
2.13.4 OncoTherapy Science Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 OncoTherapy Science Recent Developments/Updates
2.14 Peptech
2.14.1 Peptech Details
2.14.2 Peptech Major Business
2.14.3 Peptech Peptide Vaccine Product and Services
2.14.4 Peptech Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Peptech Recent Developments/Updates
2.15 Pharmasyntez
2.15.1 Pharmasyntez Details
2.15.2 Pharmasyntez Major Business
2.15.3 Pharmasyntez Peptide Vaccine Product and Services
2.15.4 Pharmasyntez Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Pharmasyntez Recent Developments/Updates
2.16 Sumitomo Dainippon Pharma
2.16.1 Sumitomo Dainippon Pharma Details
2.16.2 Sumitomo Dainippon Pharma Major Business
2.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Product and Services
2.16.4 Sumitomo Dainippon Pharma Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Sumitomo Dainippon Pharma Recent Developments/Updates
2.17 TapImmune
2.17.1 TapImmune Details
2.17.2 TapImmune Major Business
2.17.3 TapImmune Peptide Vaccine Product and Services
2.17.4 TapImmune Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 TapImmune Recent Developments/Updates
2.18 Targovax
2.18.1 Targovax Details
2.18.2 Targovax Major Business
2.18.3 Targovax Peptide Vaccine Product and Services
2.18.4 Targovax Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Targovax Recent Developments/Updates
3.1 Global Peptide Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Peptide Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Peptide Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Peptide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Peptide Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Peptide Vaccine Manufacturer Market Share in 2023
3.5 Peptide Vaccine Market: Overall Company Footprint Analysis
3.5.1 Peptide Vaccine Market: Region Footprint
3.5.2 Peptide Vaccine Market: Company Product Type Footprint
3.5.3 Peptide Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Peptide Vaccine Market Size by Region
4.1.1 Global Peptide Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Peptide Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Peptide Vaccine Average Price by Region (2019-2030)
4.2 North America Peptide Vaccine Consumption Value (2019-2030)
4.3 Europe Peptide Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Peptide Vaccine Consumption Value (2019-2030)
4.5 South America Peptide Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Peptide Vaccine Consumption Value (2019-2030)
5.1 Global Peptide Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Peptide Vaccine Consumption Value by Type (2019-2030)
5.3 Global Peptide Vaccine Average Price by Type (2019-2030)
6.1 Global Peptide Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Peptide Vaccine Consumption Value by Application (2019-2030)
6.3 Global Peptide Vaccine Average Price by Application (2019-2030)
7.1 North America Peptide Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Peptide Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Peptide Vaccine Market Size by Country
7.3.1 North America Peptide Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Peptide Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Peptide Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Peptide Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Peptide Vaccine Market Size by Country
8.3.1 Europe Peptide Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Peptide Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Peptide Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Peptide Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Peptide Vaccine Market Size by Region
9.3.1 Asia-Pacific Peptide Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Peptide Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Peptide Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Peptide Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Peptide Vaccine Market Size by Country
10.3.1 South America Peptide Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Peptide Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Peptide Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Peptide Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Peptide Vaccine Market Size by Country
11.3.1 Middle East & Africa Peptide Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Peptide Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Peptide Vaccine Market Drivers
12.2 Peptide Vaccine Market Restraints
12.3 Peptide Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Peptide Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Peptide Vaccine
13.3 Peptide Vaccine Production Process
13.4 Peptide Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Peptide Vaccine Typical Distributors
14.3 Peptide Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Peptide Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Peptide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Anergis Basic Information, Manufacturing Base and Competitors
Table 4. Anergis Major Business
Table 5. Anergis Peptide Vaccine Product and Services
Table 6. Anergis Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Anergis Recent Developments/Updates
Table 8. Antigen Express Basic Information, Manufacturing Base and Competitors
Table 9. Antigen Express Major Business
Table 10. Antigen Express Peptide Vaccine Product and Services
Table 11. Antigen Express Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Antigen Express Recent Developments/Updates
Table 13. Apitope Technology Basic Information, Manufacturing Base and Competitors
Table 14. Apitope Technology Major Business
Table 15. Apitope Technology Peptide Vaccine Product and Services
Table 16. Apitope Technology Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Apitope Technology Recent Developments/Updates
Table 18. Artificial Cell Technologies Basic Information, Manufacturing Base and Competitors
Table 19. Artificial Cell Technologies Major Business
Table 20. Artificial Cell Technologies Peptide Vaccine Product and Services
Table 21. Artificial Cell Technologies Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Artificial Cell Technologies Recent Developments/Updates
Table 23. Benovus Bio Basic Information, Manufacturing Base and Competitors
Table 24. Benovus Bio Major Business
Table 25. Benovus Bio Peptide Vaccine Product and Services
Table 26. Benovus Bio Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Benovus Bio Recent Developments/Updates
Table 28. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 29. Celgene Corporation Major Business
Table 30. Celgene Corporation Peptide Vaccine Product and Services
Table 31. Celgene Corporation Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Celgene Corporation Recent Developments/Updates
Table 33. Immatics biotechnologies Basic Information, Manufacturing Base and Competitors
Table 34. Immatics biotechnologies Major Business
Table 35. Immatics biotechnologies Peptide Vaccine Product and Services
Table 36. Immatics biotechnologies Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Immatics biotechnologies Recent Developments/Updates
Table 38. Merck Basic Information, Manufacturing Base and Competitors
Table 39. Merck Major Business
Table 40. Merck Peptide Vaccine Product and Services
Table 41. Merck Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Merck Recent Developments/Updates
Table 43. ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors
Table 44. ImmunoCellular Therapeutics Major Business
Table 45. ImmunoCellular Therapeutics Peptide Vaccine Product and Services
Table 46. ImmunoCellular Therapeutics Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. ImmunoCellular Therapeutics Recent Developments/Updates
Table 48. ISA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. ISA Pharmaceuticals Major Business
Table 50. ISA Pharmaceuticals Peptide Vaccine Product and Services
Table 51. ISA Pharmaceuticals Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. ISA Pharmaceuticals Recent Developments/Updates
Table 53. Lytix Biopharma Basic Information, Manufacturing Base and Competitors
Table 54. Lytix Biopharma Major Business
Table 55. Lytix Biopharma Peptide Vaccine Product and Services
Table 56. Lytix Biopharma Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Lytix Biopharma Recent Developments/Updates
Table 58. Spotlight Innovation Basic Information, Manufacturing Base and Competitors
Table 59. Spotlight Innovation Major Business
Table 60. Spotlight Innovation Peptide Vaccine Product and Services
Table 61. Spotlight Innovation Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Spotlight Innovation Recent Developments/Updates
Table 63. OncoTherapy Science Basic Information, Manufacturing Base and Competitors
Table 64. OncoTherapy Science Major Business
Table 65. OncoTherapy Science Peptide Vaccine Product and Services
Table 66. OncoTherapy Science Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. OncoTherapy Science Recent Developments/Updates
Table 68. Peptech Basic Information, Manufacturing Base and Competitors
Table 69. Peptech Major Business
Table 70. Peptech Peptide Vaccine Product and Services
Table 71. Peptech Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Peptech Recent Developments/Updates
Table 73. Pharmasyntez Basic Information, Manufacturing Base and Competitors
Table 74. Pharmasyntez Major Business
Table 75. Pharmasyntez Peptide Vaccine Product and Services
Table 76. Pharmasyntez Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Pharmasyntez Recent Developments/Updates
Table 78. Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
Table 79. Sumitomo Dainippon Pharma Major Business
Table 80. Sumitomo Dainippon Pharma Peptide Vaccine Product and Services
Table 81. Sumitomo Dainippon Pharma Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Sumitomo Dainippon Pharma Recent Developments/Updates
Table 83. TapImmune Basic Information, Manufacturing Base and Competitors
Table 84. TapImmune Major Business
Table 85. TapImmune Peptide Vaccine Product and Services
Table 86. TapImmune Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. TapImmune Recent Developments/Updates
Table 88. Targovax Basic Information, Manufacturing Base and Competitors
Table 89. Targovax Major Business
Table 90. Targovax Peptide Vaccine Product and Services
Table 91. Targovax Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Targovax Recent Developments/Updates
Table 93. Global Peptide Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Dose)
Table 94. Global Peptide Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 95. Global Peptide Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 96. Market Position of Manufacturers in Peptide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 97. Head Office and Peptide Vaccine Production Site of Key Manufacturer
Table 98. Peptide Vaccine Market: Company Product Type Footprint
Table 99. Peptide Vaccine Market: Company Product Application Footprint
Table 100. Peptide Vaccine New Market Entrants and Barriers to Market Entry
Table 101. Peptide Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Peptide Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
Table 103. Global Peptide Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
Table 104. Global Peptide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 105. Global Peptide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 106. Global Peptide Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 107. Global Peptide Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 108. Global Peptide Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 109. Global Peptide Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 110. Global Peptide Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 111. Global Peptide Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 112. Global Peptide Vaccine Average Price by Type (2019-2024) & (US$/Dose)
Table 113. Global Peptide Vaccine Average Price by Type (2025-2030) & (US$/Dose)
Table 114. Global Peptide Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 115. Global Peptide Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 116. Global Peptide Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 117. Global Peptide Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 118. Global Peptide Vaccine Average Price by Application (2019-2024) & (US$/Dose)
Table 119. Global Peptide Vaccine Average Price by Application (2025-2030) & (US$/Dose)
Table 120. North America Peptide Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 121. North America Peptide Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 122. North America Peptide Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 123. North America Peptide Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 124. North America Peptide Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
Table 125. North America Peptide Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
Table 126. North America Peptide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 127. North America Peptide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 128. Europe Peptide Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 129. Europe Peptide Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 130. Europe Peptide Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 131. Europe Peptide Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 132. Europe Peptide Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
Table 133. Europe Peptide Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
Table 134. Europe Peptide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Europe Peptide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 136. Asia-Pacific Peptide Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 137. Asia-Pacific Peptide Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 138. Asia-Pacific Peptide Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 139. Asia-Pacific Peptide Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 140. Asia-Pacific Peptide Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
Table 141. Asia-Pacific Peptide Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
Table 142. Asia-Pacific Peptide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 143. Asia-Pacific Peptide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 144. South America Peptide Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 145. South America Peptide Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 146. South America Peptide Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 147. South America Peptide Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 148. South America Peptide Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
Table 149. South America Peptide Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
Table 150. South America Peptide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 151. South America Peptide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 152. Middle East & Africa Peptide Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 153. Middle East & Africa Peptide Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 154. Middle East & Africa Peptide Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 155. Middle East & Africa Peptide Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 156. Middle East & Africa Peptide Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
Table 157. Middle East & Africa Peptide Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
Table 158. Middle East & Africa Peptide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 159. Middle East & Africa Peptide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 160. Peptide Vaccine Raw Material
Table 161. Key Manufacturers of Peptide Vaccine Raw Materials
Table 162. Peptide Vaccine Typical Distributors
Table 163. Peptide Vaccine Typical Customers
List of Figures
Figure 1. Peptide Vaccine Picture
Figure 2. Global Peptide Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Peptide Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Solution Phase Synthesis (SPS) Examples
Figure 5. Solid Phase Peptide Synthesis (SPPS) Examples
Figure 6. Global Peptide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Peptide Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Prostate Cancer Examples
Figure 9. Breast Cancer Examples
Figure 10. Gastric Cancer Examples
Figure 11. Lung Cancer Examples
Figure 12. Pancreatic Cancer Examples
Figure 13. Others Examples
Figure 14. Global Peptide Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Peptide Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Peptide Vaccine Sales Quantity (2019-2030) & (K Dose)
Figure 17. Global Peptide Vaccine Average Price (2019-2030) & (US$/Dose)
Figure 18. Global Peptide Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Peptide Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Peptide Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Peptide Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Peptide Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Peptide Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Peptide Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Peptide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Peptide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Peptide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Peptide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Peptide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Peptide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Peptide Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Peptide Vaccine Average Price by Type (2019-2030) & (US$/Dose)
Figure 33. Global Peptide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Peptide Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Peptide Vaccine Average Price by Application (2019-2030) & (US$/Dose)
Figure 36. North America Peptide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Peptide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Peptide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Peptide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Peptide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Peptide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Peptide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Peptide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Peptide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Peptide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Peptide Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Peptide Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 56. China Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Peptide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Peptide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Peptide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Peptide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Peptide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Peptide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Peptide Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Peptide Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Peptide Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Peptide Vaccine Market Drivers
Figure 77. Peptide Vaccine Market Restraints
Figure 78. Peptide Vaccine Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Peptide Vaccine in 2023
Figure 81. Manufacturing Process Analysis of Peptide Vaccine
Figure 82. Peptide Vaccine Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Anergis Antigen Express Apitope Technology Artificial Cell Technologies Benovus Bio Celgene Corporation Immatics biotechnologies Merck ImmunoCellular Therapeutics ISA Pharmaceuticals Lytix Biopharma Spotlight Innovation OncoTherapy Science Peptech Pharmasyntez Sumitomo Dainippon Pharma TapImmune Targovax
Related Reports
01 Apr 2021
Pharma & Healthcare
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
